- Single LSD dose provides lasting anxiety relief: Research The Hill
- MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder Yahoo Finance
- FDA designates LSD-based drug as possible breakthrough treatment for anxiety UPI News
- Psychedelic news: The government finally fast-tracked LSD as an anxiety treatment Fast Company
- MindMed’s stock soars 58% after FDA grants breakthrough designation to LSD therapy MarketWatch
Read More: Single LSD dose provides lasting anxiety relief: Research – The Hill